SAP1 Mouse

In vivo study of SAP-1 knockout; in vivo study of positive T cell selection & development

Contributors

Inventor Institute
Richard Treisman Cancer Research UK, London Research Institute: Lincoln's Inn Fields
SKU: 151554
Product description: In vivo study of SAP-1 knockout; in vivo study of positive T cell selection & development
Conditional: No
Genetic background: An Elk4 targeting vector, containing a resistance cassette inserted between exons 1 and 4, was transfected into 129 ES cells. Properly targeted ES cells containing a homologus recombination event were selected, cloned and injected into blastocysts. Chimeric offspring were backcrossed to establish heterozygous lines, and interbred to establish homozygous mice.
Production details: An Elk4 targeting vector, containing a resistance cassette inserted between exons 1 and 4, was transfected into 129 ES cells. Properly targeted ES cells containing a homologus recombination event were selected, cloned and injected into blastocysts. Chimeric offspring were backcrossed to establish heterozygous lines, and interbred to establish homozygous mice.
Additional notes: The SAP-1 mouse demonstrate a phenotype analogous to mutlicentric Castleman disease when maintained in non-sterile housing.SAP-1 mice exhibit abnormalities in T cell populations, resulting from abnormal negative selection during T cell development.
Cat. #: 151554
Research Fields: Cell signaling and signal transduction; Genetics; Immunology
Target: Elk4 / SAP-1
Disease: Castleman disease
Phenotype: The SAP-1 mouse demonstrate a phenotype analogous to mutlicentric Castleman disease when maintained in non-sterile housing.SAP-1 mice exhibit abnormalities in T cell populations, resulting from abnormal negative selection during T cell development.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Costello et al. 2004. Nat Immunol. 5(3):289-98. PMID: 14770179.

Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.